Adipose-Derived Mesenchymal Stem Cell Exosomes Suppress Hepatocellular Carcinoma Growth in a Rat Model: Apparent Diffusion Coefficient, Natural Killer T-Cell Responses, and Histopathological Features

<div>The flowchart shows the timetable for blood sampling (before and 10 days after HCC induction, posttreatment day 5 and day 15), exosome treatment (after baseline and posttreatment day 10 MR), liver MR and DW imaging (baseline, posttreatment day 10 and day 20), and final killing. Please note that two rats with typical HCC features and four rats with no HCC revealed on baseline MR imaging were killed for histopathological confirmation of MR findings.</div>

Stem Cells International

fig2

Figure 2

Figure 2: Adipose-Derived Mesenchymal Stem Cell Exosomes Suppress Hepatocellular Carcinoma Growth in a Rat Model: Apparent Diffusion Coefficient, Natural Killer T-Cell Responses, and Histopathological Features 

Figure 2 | Adipose-Derived Mesenchymal Stem Cell Exosomes Suppress Hepatocellular Carcinoma Growth in a Rat Model: Apparent Diffusion Coefficient, Natural Killer T-Cell Responses, and Histopathological Features 